Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Biotechnology
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
UnitedHealth Group (UNH) Earnings in Q4 2025
UnitedHealth Group Inc. signs on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday,…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Novo Nordisk and Pfizer executives weigh in
US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…
Keeping US biotech ahead of China could help patients with rare diseases: experts
The growth of China's biotech sector has been astonishing. Beijing is pumping money into the industry, supporting research efforts and…
Novo Nordisk shares rise after launch of anti-obesity pill Wegovy
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, on January 15, 2026. George Frey…
Abivax Stock Rises to Become Top Biotech Acquisition Target
Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…
CNBC's Becky Quick details her daughter's journey into rare diseases
I've spent the last 25 years in front of the camera here at CNBC and people have come to know…
Novo Nordisk's first GLP-1 obesity pill launched in the US
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, outside Copenhagen, on November…